检索

期
标题
作者
卷 94, 编号 8 (2022)
Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity
Starikova E., Galeeva J., Andreev D., Sokolov P., Fedorov D., Manolov A., Pavlenko A., Klimina K., Veselovsky V., Zaborovsky A., Evdokimov V., Andreev N., Devkota M., Fomenko A., Khar'kovskii V., Asadulin P., Kucher S., Cheremushkina A., Yanushevich O., Maev I., Krikheli N., Levchenko O., Ilina E., Govorun V.
PDF
(Rus)
卷 95, 编号 2 (2023)
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity
Maev I., Levchenko A., Galeeva J., Andreev D., Osipenko J., Bordin D., Ilyina E.
PDF
(Rus)
卷 95, 编号 12 (2023)
Long-term consequences of COVID-19 in patients with functional bowel disorders, rehabilitation prospective of microbiocenosis-oriented therapy
Patsenko M., Ardatskaya M., Anuchkin A., Butorova L., Gaivoronsky I., Nugaeva N., Levin V., Pavlov A., Topchiy T., Tuaeva E.
PDF
(Rus)
卷 94, 编号 10 (2022)
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
PDF
(Rus)
卷 94, 编号 2 (2022)
The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A., Lyapina M.
PDF
(Rus)
卷 96, 编号 4 (2024)
Features of the effect of a probiotic, containing Lactobacillus and Bifidobacterium on the intestinal microbiota and clinical symptoms of irritable bowel syndrome
Khalaidzheva K., Nikitina N., Astrashkova O., Drozdov V., Melkonyan G., Shikh E.
PDF
(Rus)
卷 93, 编号 12 (2021)
Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease
Mironova O., Isaikina M., Khasieva S.
PDF
(Rus)
卷 96, 编号 2 (2024)
The value and advanced features of pre- and metabiotics in the treatment of symptomatic uncomplicated diverticular colon disease
Patsenko M., Ardatskaya M., Anuchkin A., Butorova L., Gaivoronsky I., Konkova L., Levin V., Nugaeva N., Pavlov A., Topchiy T., Patsenko O.
PDF
(Rus)
卷 94, 编号 2 (2022)
Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19
Akhmedov V.
PDF
(Rus)
卷 91, 编号 11 (2019)
The value of mucosal small intestine microbiota in digestion and absorption disorders in metabolic syndrome
Lyapina M., Vakhrushev Y.
PDF
(Rus)
卷 86, 编号 3 (2014)
Role of probiotics in the prevention and treatment of diarrhea of various genesis: Focus on Linex
Ushkalova E.
卷 93, 编号 8 (2021)
Liver cirrosis and complication risk management
Bakulin I., Oganezova I., Skalinskaya M., Skazyvaeva E.
PDF
(Rus)
卷 91, 编号 4 (2019)
Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease
Danilova N., Abdulkhakov S., Grigoryeva T., Markelova M., Vasilyev I., Boulygina E., Ardatskaya M., Pavlenko A., Tyakht A., Odintsova A., Abdulkhakov R.
PDF
(Rus)
卷 85, 编号 11 (2013)
Immunotherapy for infectious diseases: challenges and prospects
Karaulov A., Kaliuzhin O.
卷 93, 编号 2 (2021)
Fecal microbiota transplantation: donor selection criteria, storage and preparation of biomaterials (review of current recommendations)
Iakupova A., Abdulkhakov S., Safin A., Alieva I., Oslopova J., Abdulkhakov R.
PDF
(Rus)
卷 90, 编号 10 (2018)
Functional insufficiency of the pancreas and the metabolic activity of the microbiota in cystic fibrosis adults patients
Vinokurova L., Baimakanova G., Krasovsky S., Silvestrova S., Dubtsova E., Varvanina G., Bordin D.
PDF
(Rus)
卷 84, 编号 2 (2012)
What we gained from a century of investigations of symbiontic intestinal microflora
Parfenov A., Bondarenko V., Parfenov A., Bondarenko V.
卷 92, 编号 10 (2020)
Gut microbiota is a factor of risk for obesity and type 2 diabetes
Demidova T., Lobanova K., Oinotkinova O.
PDF
(Rus)
卷 90, 编号 8 (2018)
NSAID-induced enteropathy: the current state of the problem
Svistunov A., Osadchuk M., Kireeva N., Hudarova A., Achkasov E.
PDF
(Rus)
卷 92, 编号 9 (2020)
Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention
Oynotkinova O., Nikonov E., Demidova T., Baranov A., Kryukov E., Dedov E., Karavashkina E.
PDF
(Rus)
卷 88, 编号 9 (2016)
Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora
Drapkina O., Korneeva O.
PDF
(Rus)
卷 92, 编号 7 (2020)
Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety
Goloshchapov O., Chukhlovin A., Bakin E., Stanevich O., Klementeva R., Shcherbakov A., Shvetsov A., Suvorova M., Bondarenko S., Kucher M., Kulagin A., Zubarovskaya L., Moiseev I.
PDF
(Rus)
卷 88, 编号 5 (2016)
Oral probiotics as anti-infectious immune response stimulators in the respiratory tract
Kalyuzhin O., Afanasyev S., Bykov A.
PDF
(Rus)
卷 92, 编号 2 (2020)
NSAID enteropathy
Kareva E.
PDF
(Rus)
卷 87, 编号 12 (2015)
Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis
Shalikiani N., Bakulin I., Dubinkina V., Ishchenko D., Alexeev D., Tyakht A., Pavlenko A., Ilyina E., Kostryukova E., Taraskina A., Skorodumova L., Maev I., Govorun V.
卷 92, 编号 3 (2020)
Changes in gut microbiota with bronchial asthma
Zolnikova O., Potskhverashvili N., Kudryavtseva A., Krasnov G., Guvatova Z., Truhmanov A., Kokina N., Ivashkin V.
PDF
(Rus)
卷 86, 编号 4 (2014)
Current views on the role of probiotics in the prevention and treatment of different diseases: Focus on Linex
Ushkalova E.
1 - 27 的 27 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##